<DOC>
	<DOCNO>NCT01576809</DOCNO>
	<brief_summary>This open label , in-use study ass warm sensation , acceptability local tolerability paracetamol 500 mg + phenylephrine 10mg + Guaifenesin 200 mg syrup , give single dose subject suffer symptom upper respiratory tract infection . The purpose evaluate acceptability concern warm sensation effect potential benefit target population . The primary objective ass warm sensation cause excipient IFF flavor 316 282 , syrup contain paracetamol 500 mg + phenylephrine 10mg + Guaifenesin 200 mg per 30 ml syrup . The syrup contain ( 0.15 % w/v ) warm flavor . The Secondary Objectives ass subject acceptability syrup safety tolerability syrup . The study run fifty-six ( 56 ) subject suffer symptom upper respiratory tract infection ( URTI ) 7 day less , e.g . nasal congestion associate cold flu symptom pain , headache and/or fever . Subjects must one symptom per category : 1. mild moderate body pain , headache , fever sore throat 2. nasal congestion ( block nose ) without rhinorrhea ( runny nose ) sneeze 3. productive cough Adolescents include study population</brief_summary>
	<brief_title>Warming Sensation Intensity Acceptability Flavour , Local Tolerability Paracetamol 500 mg + Phenylephrine 10mg + Guaifenesin 200 mg Syrup Patients Suffering Upper Respiratory Tract Infection ( URTI )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Phenylpropanolamine</mesh_term>
	<mesh_term>Chlorpheniramine , phenylpropanolamine drug combination</mesh_term>
	<mesh_term>Guaifenesin</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Subject must one symptom per category : mild moderate body pain , headache , fever sore throat nasal congestion ( block nose ) without rhinorrhea ( runny nose ) sneeze A productive cough Baseline sore throat pain severe intensity , e.g . rat 3 4point ordinal scale ( 0=not present , 1= mild , 2=moderate , 3=severe ) Baseline dry cough severe intensity , e.g . rat 3 4point ordinal scale ( 0=not present , 1= mild , 2=moderate , 3=severe ) History hypersensitivity study drug list excipients drug similar chemical class Subjects allergic asthma . Use inhaler , medicate confectionary , throat lozenge , throat pastille , spray , product demulcent property chew gum boil sweet mint , 6 hour prior dose . Use medication sore throat contain local anaesthetic within 6 hour prior dose . Use paracetamol , NSAID oral nasal decongestant within 6 hour prior dose . Use substances abuse antihistamine within 24 hour dose . Drinking tea , coffee caffeinated beverage 1 hour prior dose . Suffering hepatic severe renal impairment , hypertension , hyperthyroidism , diabetes , heart disease acute chronic medical condition , opinion investigator , would put subject high risk affect conduct and/or result study . Use antidepressant , monoamine oxidase inhibitor betablocking drug 28 day prior dose A history alcohol abuse subject admit regular consumption alcohol excess recommend weekly limit 21 unit female 28 unit male . Subject current smoker â‰¥10 cigarette per day ( report equivalent smoke habit use tobacco product ) . Subject smoke chewed tobacco product within 12 hour dose . History malignancy organ system ( localize basal cell carcinoma skin ) , treat untreated , within past 5 year , regardless whether evidence local recurrence metastasis .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Paracetamol</keyword>
	<keyword>acetaminophen</keyword>
	<keyword>phenylephrine</keyword>
	<keyword>guaifenesin</keyword>
	<keyword>syrup</keyword>
	<keyword>URTI</keyword>
	<keyword>productive cough</keyword>
</DOC>